A Reliable High-Throughput Screening Model for Antidepressant.

Area of Science:

• Neuroscience
• Pharmacology
• Animal Models

Background:

• Depression is a leading global cause of disability, necessitating effective screening methods for antidepressants.
• Current animal models for depression lack reliable high-throughput screening capabilities.
• Zebrafish are increasingly utilized as model organisms for studying mental illnesses like depression.

Purpose of the Study:

• To establish and validate a reserpine-induced depression model in zebrafish for high-throughput antidepressant screening.
• To compare the zebrafish model with established mouse models (CUMS and reserpine-induced) for behavioral and metabolic similarities.
• To assess the potential of zebrafish to replace rodents in antidepressant screening processes.

Main Methods:

• Established chronic unpredictable mild stress (CUMS) models in C57BL/6 mice and zebrafish.
• Administered reserpine to both mice and zebrafish to induce depression-like phenotypes.
• Analyzed behavioral changes (locomotor activity, exploratory behavior) and metabolic pathways (tyrosine metabolism).

Main Results:

• Reserpine induced depression-like behaviors in mice, consistent with CUMS models.
• Reserpine reduced locomotor and exploratory behaviors in zebrafish, mirroring CUMS zebrafish models.
• Metabolic analysis revealed similarities in the tyrosine metabolism pathway between reserpine-induced zebrafish, reserpine mice, and CUMS mice.

Conclusions:

• The reserpine-induced zebrafish depression model effectively replicates key features of established mouse models.
• Zebrafish serve as a viable, high-throughput alternative to rodents for antidepressant screening.
• This zebrafish model accelerates drug screening cycles and offers a reliable platform for discovering new antidepressants.